CV

Current Position

Senior Research Scientist (Directeur de Recherche), CNRS (Section 51) — since 2015.

Member of the MONC project-team, INRIA Bordeaux Sud-Ouest.

Scientific Delegate at CNRS Mathématiques, responsible for thematic research networks, sustainable development and health research topics.

Academic Career

Period	Position	Institution
2015 – present	Senior Research Scientist (CNRS, Section 51)	CNRS @ IMB
2006 – 2015	Research Scientist (CNRS, Section 01)	CNRS @ IMB

Degrees & Qualifications

Habilitation à Diriger des Recherches (HDR), Applied Mathematics — Contributions to Nonlinear Optics and Tumor Growth Modeling for Clinical Applications, Université de Bordeaux, September 25, 2012.
PhD in Applied Mathematics — Numerical Study of Nonlinearities in a Crystal by Solving Maxwell-Bloch Equations, INSA Toulouse, December 16, 2003.
Agrégation in Mathematics, 2000.
Master's in Partial Differential Equations and Scientific Computing, Université Paris Saclay, 2000.

Administrative & Scientific Responsibilities

Member of the Research Ethics Committee, Université de Bordeaux - 2024–present
Scientific Delegate, CNRS Mathématiques - 2023–present
Interdisciplinarity Officer at CNRS Mathématiques, member of the CNRS MITI Steering Committee - 2017–2023
Head of the INRIA MONC project-team - 2016–2022
Director of the CNRS GDR Metice - 2012–2016

Expert for national (ANR, Plan Cancer, PHC at MESR) and international programs (Germany, Poland, Ireland, Canada). Member of numerous PhD defense committees, recruitment panels, and steering committees (Labex TRAIL, Oncosphere, Plan Cancer HTE).

Scientific Activity

My research initially focused on mathematical modelling in nonlinear optics, then shifted to cancer modelling — capturing the key biological mechanisms underlying tumour growth and treatment response, first via PDE-based models, then by integrating clinical applications through medical imaging and artificial intelligence.

Supervision: 14 PhD theses supervised (some in joint supervision).

Software: several tools developed, one of which led to an industrial transfer (following a patent filing).

Collaborations: interdisciplinary network with teams in mathematics, biology (LAMC, BRIC), and medicine (Institut Bergonié, CHU Bordeaux, APHP, Univ. Milan, Univ. Alabama), as well as industrial partners (Roche, Sophia Genetics).

Funding: ANR, Plan Cancer, INRIA, CNRS, INSERM, Région, Plan de Relance, Fondation MSD Avenir, BPI.

Outreach: Fête de la Science, Université Populaire de Bordeaux, Scientific Days at Institut Bergonié, patient and cultural associations (ACCHLA).